Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹ÀÎ ¿ø¹ß°³¹æ°¢³ì³»Àå¿¡¼­ iStent¸¦ »ç¿ëÇÑ ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ È¿°ú¿Í ¾ÈÁ¤¼º Efficacy and Safety of iStent Trabecular Microbypass Stent in Open Angle Glaucoma in Korean

°Ë¾È ¹× ÄÜÅÃÆ®·»ÁîÇÐȸÁö 2019³â 18±Ç 3È£ p.81 ~ 85
ä¼öÇý, ÀÌÅÂÇå, ÀÌ°æÇå, ·ùÁø¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
ä¼öÇý ( Chae Sue-Hey ) 
¼º¸ð¾È°úº´¿ø

ÀÌÅÂÇå ( Lee Tae-Heon ) 
¼º¸ð¾È°úÀÇ¿ø
ÀÌ°æÇå ( Lee Kyung-Heon ) 
¼º¸ð¾È°úº´¿ø
·ùÁø¿µ ( Rhew Jin-Young ) 
¼º¸ð¾È°úº´¿ø

Abstract


Purpose: To evaluate efficacy and safety of the iStent Trabecular Micro-Bypass stent used as the sole procedure in patients with primary open-angle glaucoma (POAG).

Methods: Retrospective, consecutive case series involving 12 Korean patients, 12 eyes with POAG that were implanted with 1 iStent trabecular micro-bypass stent. Data were collected preoperatively, and at 1, 3, and 6 months, 12 months, postoperatively. Data included intraocular pressure (IOP), visual acuity test and slit lamp examination.

Results: Mean preoperative IOP was 20.6 ¡¾ 4.4 mmHg and significantly decreased in 16.3 ¡¾ 2.5 mmHg at three months (p < 0.05), in 16.6 ¡¾ 3.6 mmHg at 12 months postoperatively (p < 0.05). The mean number of glaucoma medications was 1.83 ¡¾ 0.25 preoperatively and 1.58 ¡¾ 0.30 (p < 0.05) at 12 months postoperatively. No significant changes in visual acuity were noted. The most common complications comprised mild hyphema in 3 eyes, mild uveitis in 4 eyes and transient IOP spike in 3 eyes on postoperative day 1 and all instances were medically well controlled.

Conclusions: The significat IOP reduction after iStent insertion in Korean patients occurred after one week of operation. An IOP reduction from baseline occurred at 12 months after implantation of iStent.

Å°¿öµå

Glaucoma; Glaucoma filtration implants; iStent; Intraocular pressure

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸